Cingulate Inc (CING) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $6.49
• Market Cap: $47.21M
• EPS: $-2.77
• 52-Week High: $7.92
• 52-Week Low: $3.20

Market Sentiment

Cingulate Inc currently has a Bullish sentiment score of 0.32.

About Cingulate Inc

Cingulate Inc. is a clinical-stage biopharmaceutical company headquartered in Kansas City, Kansas, focusing on innovative therapies for neurobiological and central nervous system disorders. The company is advancing a pipeline of proprietary drug candidates aimed at addressing critical unmet needs in the fields of psychiatry and neurology. With its specialized platform designed to optimize therapeutic efficacy, Cingulate is strategically positioned to make a meaningful impact on the future of ...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Cingulate Inc and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does CING pay dividends?

Cingulate Inc (CING) does not currently pay a regular dividend.

What is CING's market cap?

Cingulate Inc (CING) has a market capitalization of $47.21M with a current stock price of $6.49.